Belzutifan is an inhibitor focused on the HIF-2 pathway. This pathway is key in how cells react to low oxygen levels. It’s mainly used for RCC that’s linked to Von Hippel-Lindau disease.
You can get Belzutifan as 40 mg tablets with a coating. You’re supposed to take 120 mg of it every day. That’s three tablets for each dose.
Each bottle of Belzutifan has 90 of those tablets. Belzutifan helps reduce oxygen levels in tumors, which can help manage or slow RCC growth. It’s really important to stick with the dose your doctor tells you to use and to talk to them for the best results.
Reviews
There are no reviews yet.